267 related articles for article (PubMed ID: 8466498)
21. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
22. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
23. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Tranter HS; Acharya KR
J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
[TBL] [Abstract][Full Text] [Related]
25. Enterotoxin residues determining T-cell receptor V beta binding specificity.
Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
[TBL] [Abstract][Full Text] [Related]
26. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
[TBL] [Abstract][Full Text] [Related]
27. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression.
Mehindate K; al-Daccak R; Damdoumi F; Mourad W
Eur J Immunol; 1996 Sep; 26(9):2075-80. PubMed ID: 8814249
[TBL] [Abstract][Full Text] [Related]
29. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
[TBL] [Abstract][Full Text] [Related]
30. Modeling of receptor mimics that inhibit superantigen pathogenesis.
Möllhoff M; Zanden HB; Shiflett PR; Gupta G
J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
[TBL] [Abstract][Full Text] [Related]
31. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC.
Wang S; Li Y; Xiong H; Cao J
Immunol Lett; 2008 Dec; 121(2):167-72. PubMed ID: 19028523
[TBL] [Abstract][Full Text] [Related]
32. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.
Arcus VL; Proft T; Sigrell JA; Baker HM; Fraser JD; Baker EN
J Mol Biol; 2000 May; 299(1):157-68. PubMed ID: 10860729
[TBL] [Abstract][Full Text] [Related]
33. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1.
Scholl PR; Trede N; Chatila TA; Geha RS
J Immunol; 1992 Apr; 148(7):2237-41. PubMed ID: 1545128
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
[TBL] [Abstract][Full Text] [Related]
35. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes.
Lamphear JG; Bohach GA; Rich RR
J Immunol; 1998 Mar; 160(5):2107-14. PubMed ID: 9498747
[TBL] [Abstract][Full Text] [Related]
36. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
37. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
Tiedemann RE; Fraser JD
J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
[TBL] [Abstract][Full Text] [Related]
38. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
[TBL] [Abstract][Full Text] [Related]
40. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule.
Fernández MM; De Marzi MC; Berguer P; Burzyn D; Langley RJ; Piazzon I; Mariuzza RA; Malchiodi EL
Mol Immunol; 2006 Mar; 43(7):927-38. PubMed ID: 16023209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
